PhD candidates

Current: 

Henrik Horndalsveen
Durvalumab after chemoradiation for stage III non-small lung cancer patients – the DART study
Supervisors: Åslaug Helland (main), Vilde Drageset Haakensen (co), Maria Moksnes Bjaanæs (co)

Saima Farooqi
Circulating cytokines in patients treated with double immunotherapy with our without UV1 vaccination – relation to side effects and clinical benefit
Supervisors: Vilde Drageset Haakensen (main), Åslaug Helland (co), Åsa Öjlert (co), Maria Moksnes Bjaanæs (co)

Hanne Marte Gjertsen Nymoen
Thoracic radiotherapy combined with systemic treatment for patients with non-small cell lung cancer – clinical effect and gut microbiome biomarkers
Supervisors: Vilde Drageset Haakensen (main), Åslaug Helland (co), Tine Alver (co), Maria Moksnes Bjaanæs (co)

Solfrid Thunold
PET-features as biomarkers for immune response and clinical effect for patients with pleural mesothelioma treated with ipilimumab and nivolumab with or without UV1 vaccine
Supervisors: Vilde Drageset Haakensen (main), Eirik Malinen (co), Eivor Hernes (co), Åslaug Helland (co)

Alumni: 

Maria Moksnes Bjaanæs (2016)
Molecular characterization of non-small cell lung cancer tumors
Supervisors: Åslaug Helland (main), Odd Terje Brustugun (co)

Camilla Sagerup (2016)
Epidemiological and molecular characteristics of lung cancer. Population-based and molecular studies.
Supervisors: Odd Terje Brustugun (main), Åslaug Helland (co)

Ann Rita Halvorsen (2017)
Circulating microRNAs; biomarkers for early detection, prediction of therapy response and prognosis in cancer patients.
Supervisors: Åslaug Helland (main), Vilde Drageset Haakensen (co)

Marc Kevin McGowan (2019)
Drug-Resistance and Protective Factors in NSCLC
Supervisors: Odd Terje Brustugun (main), Åslaug Helland (co)

Hanne Eide (2020)
Serum and tumour biomarkers in non-small cell lung cancer
Supervisors: Åslaug Helland (main)

Åsa Öjlert (2021)
The non-small cell lung cancer tumor immune microenvironment: implications for treatment and prognosis
Supervisors: Åslaug Helland (main)

Inger Johanne Zwicky Eide (2023)
Novel EGFR-directed therapy – a clinical study
Supervisors: Odd Terje Brustugun (main), Åslaug Helland (co)

Janna Berg (2023)
Pulmonary function and serum biomarkers in patients with non-small cell lung cancer, radiation pneumonitis and chronic obstructive lung disease
Supervisors: Åslaug Helland (main)